Animal studies have amply demonstrated that stress exposure during pregnancy or in early postnatal life can adversely influence brain development and have long-term 'programming' effects on future brain function and behaviour. Furthermore, a growing body of evidence from human studies supports the hypothesis that some psychiatric disorders may have developmental origins. Here, the focus is on three adverse consequences of early-life stress: dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, heightened anxiety behaviour and cognitive impairments, with review of what is known about the underlying central mechanisms. Neuroactive steroids modulate neuronal activity and play a key role in neurodevelopment. Moreover they can negatively modulate activity of the HPA axis, exert anxiolytic actions and influence cognitive performance. Thus, neuroactive steroids may provide a link between early-life stress and the resultant adverse effects on the brain and behaviour. Here, a role for neuroactive steroids, in particular the 5a-reduced/3a-hydroxylated metabolites of progesterone, testosterone and deoxycorticosterone, is discussed in the context of early-life stress. Furthermore, the impact of earlylife stress on the brain's capacity to generate neurosteroids is considered and the evidence for an ability of neuroactive steroids to over-write the negative effects of early-life stress on the brain and behaviour is examined. An enhanced understanding of the influence of early-life stress on brain neurosteroid systems could aid the identification of new targets for developing treatments for stress-related conditions in humans.
Introduction
The perinatal period is a time of active neuroplasticity when the developing brain undergoes complex processes (e.g. neurogenesis, synaptogenesis, dendritic and axonal arborisation, programmed cell death and myelination) and as such, brain development and neuronal organisation is particularly vulnerable to insults at this time. Insults such as stress during the perinatal period can detrimentally 'programme' the infant's brain, leading to profound alterations in neuroanatomy, physiological and neuroendocrine function and behaviour in later life. The phenomenon of 'early-life programming' of the brain and behaviour is well established in rodents (1) , and a growing body of evidence supports the idea that various childhood/ adulthood disorders in humans have their origins in early life. For example, in women, maternal stress exposure during pregnancy is associated with an increased incidence of neurodevelopmental disorders (e.g. attention deficit disorder, autism, schizophrenia), affective disorders (e.g. anxiety, depression), cognitive deficits and emotional/behavioural problems in their children later in life (2) . The neuroendocrine stress axis, the hypothalamic-pituitary-adrenal (HPA) axis, is particularly vulnerable to early-life programming by stress (1, 3) and the resultant HPA axis dysfunction may underpin psychiatric disorders and disrupted cognitive processing (4, 5) .
Neuroactive steroids (endogenous steroids that exert rapid nongenomic effects on neuronal excitability) play a significant role in neurodevelopment in terms of neuroprotection and neuronal organisation: they promote neuronal survival and differentiation, myelinisation, dendritic growth and synaptogenesis (6) (7) (8) . Hence, it is perhaps unsurprising that several neurodevelopmental disorders, mood disorders and cognitive decline have been associated with a perturbation in neurosteroid levels (9) (10) (11) (12) (13) (14) (15) (16) . Thus, neurosteroids may provide a link between early-life stress and adverse programming of the brain and behaviour.
Here, a role for neuroactive steroids in the context of early-life stress is discussed, focussing on three adverse consequences of stress exposure during development: HPA axis dysregulation, increased anxiety and impaired cognitive ability. First, these detrimental effects of early-life stress and what is known about the central mechanisms involved are reviewed. Next, the role of neuroactive steroids in modulating HPA axis function, anxiety behaviour and cognitive performance is considered before a discussion of the impact of early-life stress on neurosteroidogenesis and, finally, the potential for neuroactive steroids in counteracting the negative effects of early-life stress on the brain and behaviour is examined.
Effects of early-life stress on the brain and behaviour
Much of the work investigating the effects of early-life stress on the brain and behaviour has been performed in rodents. Numerous rodent models of prenatal stress exposure are described in the literature, although these typically involve exposing a pregnant animal to the same stressor (e.g. restraint) repeatedly (17) or to a variety of different stressors (e.g. cold, forced swimming, overcrowding, restraint) in an unpredictable fashion (18) during a specific period of gestation. Stress in the early postnatal period is frequently achieved by disrupting the dam-pup interaction; for example, by repeatedly separating pups from their mothers for a few hours per day during the first 2-3 weeks of life (19, 20) . In rats, maternal exposure to stress during pregnancy or maternal deprivation in early postnatal life is associated with heightened anxiety-like behaviours (17, (21) (22) (23) , HPA axis dysregulation (18, 21, 22, (24) (25) (26) , impaired neural development (27) , cognitive deficits (27) (28) (29) and aberrant social behaviours (30) (31) (32) (33) in the offspring. In human studies, maternal stress and anxiety during pregnancy is also associated with impaired infant neurodevelopment, including delayed motor development, cognitive impairments, emotional problems, negative temperament and symptoms of attention deficit disorder (34) (35) (36) (37) .
HPA axis dysregulation
Enhanced or prolonged HPA axis responses to stress is a key feature in animals exposed to stress in early life, either pre-or postnatally (19, 20, 22, 25, 38) . The central mechanisms underpinning HPA axis dysregulation appear to involve changes in both excitatory feedforward and inhibitory feedback mechanisms ( Fig. 1 ).
Excitatory inputs
Exaggerated adrenocorticotrophic hormone (ACTH) and corticosterone responses to stress induced by early-life stress are associated with marked up-regulation in corticotrophin-releasing hormone (CRH) mRNA expression in the parvocellular neurones of the paraventricular nucleus (PVN) (22, (39) (40) (41) , indicative of increased excitatory input to the CRH neurones. Indeed enhanced excitatory glutamatergic drive to the CRH neurones in the PVN has recently been demonstrated in a mouse model of early-life stress (39) ( Fig. 1 ).
Inhibitory inputs
Glucocorticoid (GR) and mineralocorticoid receptors (MR) mediate negative-feedback control of the HPA axis by glucocorticoids. Enhanced and prolonged HPA axis responses to stress are associated with reduced hippocampal expression of GR, MR or both receptors (22, 25, 38, 42, 43) , indicating a possible impairment of glucocorticoid negative-feedback ( Fig. 1 ).
Insufficient inhibitory GABA input may also play a role. GABAergic neurones that project to the PVN modulate HPA axis activity, resulting in inhibition of the CRH neurones (via glutamatergic activation of PVN projecting GABAergic neurones) or activation of the CRH neurones (via GABAergic inhibition of PVN projecting GABAergic neurones; i.e. disinhibition) (44) . Prenatal stress results in a reduction in the density of parvalbumin-positive GABAergic interneurones in the medial prefrontal cortex and hippocampus (45,46) ( Fig. 1) . Moreover, the number of GABA A receptors is significantly reduced in the hippocampus and the central amygdala in prenatally stressed offspring compared to controls (47,48) ( Fig. 1 ). Whether these changes in GABAergic signalling underlie enhanced HPA axis responses to stress after early-life stress remains to be determined; however, it is interesting to note that a reduction in inhibitory GABA interneurones and/or GABA receptor expression is reported in several neuropsychiatric disorders, such as schizophrenia, autism, anxiety and Tourette's syndrome, and that these disorders have also been linked to prenatal stress exposure (49) .
Anxiety behaviour
An anxiety-like phenotype is frequently observed in animals exposed to early-life stress. This has been demonstrated by Examples of indicators of these adverse phenotypes are given together with a summary of the neural correlates and potential central mechanisms involved. ↑, increased/enhanced; ↓, decreased/supressed compared with control animals; BDNF, brain-derived neurotrophic factor; CRH, corticotrophinreleasing hormone; CRH-R1, CRH receptor type 1; CRH-R2, CRH receptor type 2; EPM, elevated plus maze; GC, glucocorticoid; hippo, hippocampus; LTP, long-term potentiation; MWM, Morris water maze. increased ultrasonic vocalisations in neonates (50) , reduced social play during adolescence (51) , reduced open arm entries on the elevated-plus maze test (22, 23, 52) and decreased exploration in an open field (17,53,54) ( Fig. 1 ).
Anxious behaviours are organised by the amygdala and CRH is importantly involved in mediating anxiety responses (55, 56) . CRH content is increased in the amygdala of prenatally stressed rodents (22, 57, 58) , as is CRH release from amygdala homogenates (57) ( Fig. 1 ). Increased anxiety-behaviour in adult prenatally stressed offspring is associated with enhanced CRH receptor binding in the amygdala (56) and can be attenuated by central administration of non-selective CRH receptor antagonists (56) , indicating that altered CRH receptor expression is likely to be important in the expression of anxiety-like behaviours induced by early-life stress. Indeed, studies using conditional forebrain CRH type 1 receptor (CRH-R1) knockout mice have further highlighted the importance of CRH-R1 in facilitating anxiogenic behavioural responses induced by early-life stress (59) . Furthermore, increased anxiety-like behaviour in prenatally stressed rats is associated with increased expression of CRH-R1 mRNA in the central and basolateral nuclei of the amygdala (60), the PVN (21,61) and, more recently, this has also been demonstrated in the amygdala of prenatally stressed pigs (62) ( Fig. 1 ). Altered expression of the CRH type 2 receptor (CRH-R2) is also likely to influence anxiety behaviour. By contrast to CRH-R1, activation of CRH-R2 is considered to have anxiolytic actions (63, 64) . In line with this is the finding of reduced CRH-R2 expression in the amygdala of prenatally stressed rats that display an anxious phenotype (40,60) ( Fig. 1 ).
Altered glutamate neurotransmission has also been implicated in anxious behavioural responses. Heightened anxiety-like behaviour in prenatally stressed rats is correlated with reduced glutamate release in the ventral hippocampus (65) , which can be reversed with antidepressant treatment (66).
Cognitive impairments
Cognitive impairments observed after early-life stress have been demonstrated in rodents using learning and memory tasks such as the Morris water maze, Barne's maze and the novel object recognition test (27, 28, (67) (68) (69) . The hippocampus is highly susceptible to the programming effects of stress during the perinatal period and the resultant cognitive deficits are associated with alterations in hippocampal structure and function, including reduced neurogenesis (27, 70, 71) , reduced brain-derived neurotrophic factor expression (72, 73) , decreased long-term potentiation (LTP) (74) (75) (76) and altered synaptic plasticity (e.g. reduced spine density, reduced dendritic length, dendritic atrophy and altered mossy fibre density) in rodents (69,76-81) ( Fig. 1) . Importantly, the consequences of early-life stress on cognitive performance and hippocampal function are long term and evidently persist throughout life (in contrast to the reversible effects of chronic stress on cognitive function in adulthood) (82) . Moreover, many of these consequences are sex-specific (67, 68, 80, 81, 83, 84) , potentially implicating a role for modulation by sex steroids, and are exacerbated by ageing (53, 76) .
It is not yet clear what 'factor' mediates these effects of earlylife stress on hippocampal structure and function and hence impairs cognitive performance; however, CRH has been implicated. CRH expression in the PVN is markedly elevated in several models of early-life stress (19, 39, 40, 85) , although there is also evidence that CRH expression is augmented in the hippocampus in adult prenatally stressed rats (86) and in middle-aged rats exposed to stress (induced by fragmented maternal care) in early postnatal life (69) ( Fig. 1 ). Type 1 CRH receptors are located on hippocampal neurones (87, 88) and CRH is known to mediate the effects of acute stress on hippocampal synaptic plasticity and cognitive performance (89, 90) . Indeed, prolonged exposure to CRH reduces dendritic complexity in cultured hippocampal neurones (69) in a similar manner to that induced by early-life stress (76) . Moreover, central administration of CRH to rats in early life mimics the effects of early-life stress in adulthood in terms of impaired memory and hippocampal cell loss and is associated with an up-regulation of CRH and CRH-R1 gene expression in hippocampal pyramidal cells (91) . Thus, increased CRH action in the hippocampus may contribute to the central mechanisms underlying the effects of stress during early life on hippocampal structure and function. In support of this, treatment with a CRH-R1 antagonist shortly after stress exposure in early postnatal life has been demonstrated to prevent the deficits in learning and memory, dendritic atrophy and suppressed LTP observed in later life (69) . Furthermore, impairments in spatial learning and memory and the associated disrupted LTP and reduced hippocampal dendritic spine density, as induced by early-life stress in wild-type mice, are not observed in conditional forebrain CRH-R1 knockout mice raised under the same conditions (92) .
Additionally, given the critical role of the hippocampus in performing learning and memory tasks and the well described impact of corticosteroids on hippocampal-dependent learning (93) , it is likely that reduced levels of hippocampal GR and/or MR in animals exposed to early-life stress (22, 25, 38) may also contribute to alterations in cognition, although this requires further investigation.
Neuroactive steroids
The term 'neuroactive steroid' refers to active metabolites of classical steroid hormones that, independent of their origin (i.e. those produced in the brain or in the periphery), have rapid membrane actions on neuronal excitability. The brain can produce these neuroactive steroids and, when synthesised centrally, they are frequently referred to as 'neurosteroids' (94, 95) . Production of neuroactive steroids in the brain (i.e. neurosteroids) is dependent upon the expression of the relevant enzymes, which can show important regional differences (96) . Amongst the most extensively studied neuroactive steroids are the progesterone metabolite, allopregnanolone (3a-hydroxy-5a-pregnan-20-one, also 3a,5a-tetrahydroprogesterone) and 5a,3a-tetrahydrodeoxycorticosterone (THDOC) a metabolite of deoxycorticosterone (DOC). For allopregnanolone synthesis, progesterone is first converted into dihydroprogesterone (DHP; 20a-hydroxy-4-pregnen-3-one) by 5a-reductase (the rate limiting enzyme), which in turn is converted into allopregnanolone by the actions of 3a-hydroxysteroid dehydrogenase (3aHSD) (Fig. 2) . THDOC is synthesised from the adrenal ste-roid DOC (via the intermediate 21-hydroxy-5a-pregnane-3,20-dione) by the action of the same two enzymes ( Fig. 2 ). Both of these enzymes are expressed in the brain by astrocytes and oligodendrocytes (97-99) and 5a-reductase activity is also evident in neurones (100) . Although the brain is capable of synthesising progesterone from pregnenolone and subsequently reducing progesterone to allopregnanolone (via DHP), DOC is formed from progesterone in the adrenal cortex but not in the brain (97, 98, (101) (102) (103) . Nonetheless, DOC can be converted to THDOC in the brain via the actions of 5areductase and 3aHSD (98, 104) . 5a-reductase also converts testosterone into the more potent androgen, dihydrotestosterone (DHT), which in turn can be converted into 3a-androstandiol (5a-androstane-3a,17b-diol; hereafter 3a-diol) by 3aHSD or 3b-androstandiol (5aandrostane-3b,17b-diol; hereafter 3b-diol) by the actions of 3aHSD, 3bHSD and 17bHSD (105,106) ( Fig. 2) , including in the brain (107, 108) . By contrast to 3a-diol, the formation of 3b-diol is irreversible (106) .
Neuroactive steroids and neuromodulation
Neuroactive steroids can rapidly alter neuronal excitability by binding to membrane bound ion channel-linked receptors (95) . The GABA A receptor is the principal mediator of GABAergic neurotransmission in the central nervous system (CNS). GABA A receptors are ligand-gated chloride channels comprised of five subunits, with 19 different subunit types having been identified to date. The assembly of five subunits to form GABA A receptors results in a complex heterogeneity in their structure (which determines regional expression in the CNS and their pharmacological profile); however, the most common type in the brain is a pentamer consisting of two a subunits, two b subunits and either a c or d subunit. When activated by GABA, the channel opens, permitting chloride ion influx and thus hyperpolarisation of the cell membrane.
Allopregnanolone, THDOC and 3a-diol are potent positive modulators of GABA A receptors; they augment the inhibitory actions of GABA by prolonging the opening time of chloride ion channels within GABA A receptors (109) (110) (111) . Subunit composition confers sensitivity of the GABA A receptor to modulation by neuroactive steroids, with allopregnanolone having greater efficacy at GABA A receptors containing the d subunit (112) . Thus, neuroactive steroids can modulate neuronal activity by binding to neurotransmitter receptors, hence influencing brain function and behaviour. By contrast to 3a-diol, 3b-diol does not enhance the action of GABA (113) and, instead, it can serve as an oestrogen receptor-b (ERb) agonist in the brain (114) . Despite the different mechanisms of action, all of these neuroactive steroids are able to modulate neuronal activity. Below, the focus is on the role of neuroactive steroids in modulating the HPA axis, anxiety behaviour and cognition.
Role in modulating HPA axis function
Acute stress results in an increase in allopregnanolone and THDOC levels in the blood and brain, which negatively modulates HPA axis activity, facilitating termination of the stress response and restoring physiological homeostasis (101) . Administration of allopregnanolone has been shown to attenuate stress-induced HPA axis activity in male (115) and female rats (116) , to attenuate stimulated CRH release from hypothalamic explants and to prevent adrenalectomy- induced up-regulation of CRH gene expression in the PVN (117) . Similarly THDOC administration attenuates the stress-induced increase in corticosterone secretion (118) . In male rats, the suppressive actions of testosterone on stress-induced HPA axis activity are mediated by the 5a-reduced metabolite of testosterone, DHT, and its metabolite, 3b-diol (114, 119, 120) . Moreover, treatment with the 5a-reductase inhibitor, finasteride results in enhanced/prolonged ACTH and corticosterone responses to acute stress (116, 120) . However, central levels of allopregnanolone and 5a-reductase activity are reduced after chronic stress exposure (121) (122) (123) (124) . In mice, chronic social isolation leads to a dramatic reduction in 5areductase 1 mRNA expression in glutamatergic neurones in the hippocampus, basolateral amygdala and the medial prefrontal cortex (124) . Interestingly, in humans, a similar reduction is observed in the prefrontal cortex of depressed patients (125) . In rats, chronic social isolation also results in reduced circulating and hippocampal levels of allopregnanolone and is associated with a depressive-/anxiety-like phenotype and reduced glucocorticoid feedback sensitivity of the HPA axis (126) . Importantly, these effects can be prevented if allopregnanolone is administered from the onset of the stress period or can be reversed when allopregnanolone is administered chronically after cessation of the stress exposure (126) .
Role in modulating anxiety behaviour
Down-regulation of neuroactive steroid production has a potential causal role in affective disorders, such as anxiety and depression. Reduced neuroactive steroid levels, particularly of allopregnanolone, have been reported in the blood and cerebrospinal fluid of patients with anxiety disorders, depression (major depression and post-partum depression), post-traumatic stress disorder and schizophrenia (9, 125, (127) (128) (129) (130) (131) .
5a-reduced/3a-hydroxylated neuroactive steroids such as allopregnanolone, THDOC and 3a-diol have potent anxiolytic properties, in accordance with their ability to act as positive allosteric modulators at the GABA A receptor. Allopregnanolone, THDOC and 3a-diol have been demonstrated to reduce anxiety-like behaviours in rodent tests of anxiety, including the elevated plus maze (132) (133) (134) (135) (136) , lightdark box (134, 136, 137) and defensive freezing task (138) , and also to reduce ultrasonic vocalisations in neonates in response to maternal separation (139, 140) . Moreover, allopregnanolone blocks CRHinduced anxiogenic behaviour (117) . The anxiolytic effects of allopregnanolone can be blocked with a GABA A receptor chloride channel blocker (132) , indicating that the anxiolytic effects of allopregnanolone are mediated via GABA A receptors. Furthermore, studies where allopregnanolone has been directly infused into the amygdala or the medial prefrontal cortex implicate these brain regions as potential sites for anxiolytic actions of allopregnanolone (141, 142) .
Role in cognition
Cognitive processing is also influenced by neuroactive steroids, although there are differing reports in the rodent literature on the direction of the effects. For example, allopregnanolone has been demonstrated to improve memory performance in the novel object recognition test (143) and Morris water maze (144) in female rats, whereas other studies have reported allopregnanolone impairs spatial memory in male rats (145, 146) . The neuroactive metabolite of testosterone, 3a-diol, has also been reported to enhance cognition in rats and mice (136) and 3b-diol improves performance in the Morris water maze (147) .
Reasons for the discrepancies may relate to the different dose and drug administration regimes, the age and sex of the animals, the behavioural tests used and the sedative/hypnotic/anaesthetic effects of neuroactive steroids that are positive modulators at GABA A receptors (148) . It is important to note that rodent tests of cognition should be interpreted with caution, especially in the case of neuroactive steroid effects, because many tests rely on an aversive or stress-invoking component. For example, the water maze, as commonly used to assess spatial memory, involves forced swimming, which is a robust stressor in rodents (149, 150) . The test relies on the animals finding the water 'aversive' and/or being sufficiently 'stressed' in order to motivate them to escape onto the hidden platform. Given the anxiolytic and stress suppressive actions of allopregnanolone (discussed above), one can envisage how findings from this type of behavioural test could be skewed (i.e. an increased latency to find the escape platform may not necessarily represent memory impairment but, rather, it may result from a reduced motivation to escape if the test is perceived as being less anxiogenic/stressful).
Nevertheless, neuroactive steroids, in particular allopregnanolone, have established neuroprotective actions in models of injury or disease (151) . For example, in a transgenic mouse model of Alzheimer's disease (where allopregnanolone concentrations in the cerebral cortex are markedly lower than in wild-type mice), allopregnanolone treatment has been shown to promote neurogenesis and to reverse learning and memory deficits (152) , implicating allopregnanolone as a potential therapeutic for cognitive deficits.
Effects of early-life stress on neurosteroidogenesis and neuroactive steroid actions in the offspring
Given the critical role neuroactive steroids play in neurodevelopment, disruption of neurosteroidogenesis during pregnancy/early postnatal life is potentially damaging to the brain and may lead to altered development of the systems that regulate stress responses, mood, behaviour and cognitive function. Below, the influence of stress exposure in early life on neurosteroidogenesis in the brain of the fetus/neonate is considered and the evidence for these effects persisting into later life is discussed.
Neurosteroidogenesis in the placenta and foetal brain
There is evidence to show that prolonged exposure to elevated glucocorticoid levels or exposure to stress during pregnancy may reduce the capacity of the foetal brain to synthesise neurosteroids. Exposing pregnant rats to immobilisation stress on days 15-18 of pregnancy decreases 5a-reductase activity in the cerebral cortex and hypothalamus of the male fetuses on embryonic day 19 (153) and repeated betamethasone administration during gestation in the guinea pig results in reduced 5a-reductase type 2 expression in the placenta with a concomitant reduction in the foetal hippocampus (154) . Moreover, in rats, dams exposed to stress in late pregnancy have lower levels of circulating allopregnanolone at birth and this predicts reduced allopregnanolone production in the brains of the offspring in postnatal life (28) . These data suggest that exposure to elevated glucocorticoids as a result of stress, influences the neurosteroidogenic capacity of the placenta and the foetal brain.
Neurosteroidogenesis in the neonate, juvenile, adult
A reduced capacity for neurosteroidogenesis in the foetal brain as a result of prenatal stress exposure appears to persist into postnatal life. In rats, the male and female juvenile offspring of mothers exposed to either repeated restraint or chronic variable stressors during late pregnancy display reduces the conversion of progesterone into its 5a-reduced metabolites in the medial prefrontal cortex compared to control offspring; an effect that is associated with impaired cognitive development and reduced dendritic spine density in the dorsal hippocampus (28, 79) . Similar cognitive deficits are observed in the offspring of mothers who were treated with finasteride (a 5a-reductase inhibitor that blocks neuroactive steroid generation) in late pregnancy (155) . Moreover, progesterone utilisation (the ratio of allopregnanolone and DHP to progesterone) is also markedly reduced in the hippocampus of female juveniles born to mothers exposed to immune challenge in late pregnancy (29) . Reduced DHP production (indicating reduced 5a-reductase activity) is also seen in the brains of neonates exposed to maternal separation and social isolation stress in early postnatal life (156) . In adult males, prenatal stress is associated with reduced levels of DHT and 3a-diol (5a-reduced metabolites of testosterone) in the hippocampus (157) and with increased corticosterone responses to acute stress, anxiogenic behaviour and reduced social interaction (157) .
The findings of reduced 5a-reduced metabolites in the brains of animals exposed to early-life stress (be it pre-or postnatally) indicate reduced expression and/or activity of 5a-reductase. Indeed, we have recently demonstrated that, in adult male rats, prenatal stress is associated with reduced 5a-reductase mRNA expression in the PVN and nucleus tractus solitarii (NTS) (158) , whereas, in adult females, 5a-reductase mRNA expression is down-regulated compared to control females only in the NTS. The reason for the sex difference is not clear, although this may result from differences in circulating androgens (159) (160) (161) . Indeed, hepatic 5a-reductase activity is programmed during development by testosterone levels: castration increases and testosterone administration reduces hepatic 5a-reductase activity (162) . In accordance, circulating testosterone levels are increased in adult male rats whose mothers were exposed to social stress in late pregnancy (158) and there is a concomitant reduction in 5a-reductase mRNA expression in the liver (163) . Moreover, testosterone levels are significantly greater in the adolescent children born to women who were exposed to stress (associated with the Chernobyl disaster) from the second trimester of pregnancy onwards, indicating prenatal programming of testosterone levels in humans (164) . Thus, elevated circulating testosterone levels in prenatally stressed males may contribute to reduced 5a-reductase expression in the liver and/or brain. Moreover, reduced 5a-reductase activity in the periphery could potentially also contribute to reduced neuroactive steroid levels in the brain.
In juveniles, social isolation rearing postweaning has also been shown to reduce expression of 5a-reductase isoforms 1 and 2 in the nucleus accumbens and medial prefrontal cortex and is associated with reduced allopregnanolone and THDOC levels in the frontal cortex of male rats (165) . Human studies further indicate that reduced 5a-reductase activity may contribute to some of the negative phenotypes observed in individuals exposed to stress in early life. 5a-reductase type 1 activity is markedly reduced in adult survivors of the World War II Holocaust. Intriguingly, the largest reductions in 5a-activity are observed in individuals who were youngest at the time of the Holocaust (166), highlighting a potential developmental 'programming' window. Moreover, there is evidence for intergenerational transmission of the adverse effects of Holocaust exposure from survivors to their offspring that involves epigenetic mechanisms (167, 168) . Whether epigenetic mechanisms might explain reduced 5a-reductase gene expression after early-life stress requires further study; however, altered DNA methylation has been demonstrated for other genes (e.g. GR, CRH, CRH-R1) in rodent models of early-life stress (19, 58, 61) , in those exploiting natural variations in maternal care (169) and in humans in the offspring of parents with post-traumatic stress disorder (168) .
Early-life stress evidently also interferes with neuroactive steroid action in the brain. Gunn et al. (39) have elegantly demonstrated that early-life stress (using a mouse model of fragmented maternal care) enhances excitatory glutamatergic drive to CRH-expressing neurones in the PVN of neonates and is associated with increased CRH expression in the PVN. Moreover, they have shown that, although allopregnanolone potently supresses CRH neuronal firing in controls, the same treatment is ineffective on these neurones in hypothalamic slices from neonatal mice exposed to early-life stress (39) . Importantly, this neuroactive steroid insensitivity is not a result of allopregnanolone becoming less effective in modulating GABA A receptor function but, rather, it is a consequence of the increased glutamatergic drive onto the PVN CRH neurones (39) . A similar finding is observed in the neonatal offspring of GABA A receptor d-subunit knockout mice (which also display abnormal maternal care) (39) , indicating that modulation of neuronal activity by neuroactive steroids during the neonatal period may be critical for normal development of the HPA axis (and hence for 'normal' HPA axis responses in later life), as has been demonstrated for the normal development of GABAergic systems in the prefrontal cortex (170) .
A role for neuroactive steroids in counter-acting the adverse effects of early-life stress
Neuroendocrine stress responses and anxiety-related behaviour
Given the role of neuroactive steroids in modulating neuroendocrine stress responses, anxiety behaviour and cognitive function (discussed above), as well as the findings that stress during early pre-or postnatal life alters neurosteroidogenesis, it can be hypothesised that altered neuroactive steroid production and/or action may underpin some of the adverse effects of early-life stress described earlier and thus neuroactive steroid administration may counteract or reverse some of the adverse effects associated with early-life stress.
Studies in the 1990s first demonstrated a role for neuroactive steroids in reversing or preventing some of the neuroendocrine and behavioural consequences of stress exposure in early life. Allopregnanolone treatment was shown to significantly reduce maternal separation-induced ultrasonic vocalisations (an indicator of anxiety) in neonates (140) , with the effect of allopregnanolone mediated via GABA A receptors (139) . Moreover, the increased anxiety-like behaviour observed in adult prenatally stressed offspring can be prevented if pregnant dams are administered allopregnanolone in parallel with the stress exposure during the last week of gestation (171) . Administration of THDOC, another 5a-reduced metabolite and a potent positive allosteric modulator of the GABA A receptor, during early postnatal life abolishes the adverse behavioural and neuroendocrine effects induced by repeated maternal separation in early life that are observed in adulthood, such as increased anxiety, enhanced HPA axis responses to stress and impaired glucocorticoid feedback (172) . Taken together, these data indicate that, during development, neuroactive steroids that act as positive modulators at the GABA A receptor may have stress-protective actions in the brain.
More recently, it has been demonstrated that peripheral administration of allopregnanolone over a period of 20 h is sufficient to normalise ACTH secretory responses to an acute physical stressor in adult female rats born to mothers exposed to repeated social stress during pregnancy (158) (Fig. 3A) . Moreover, adenovirus-mediated gene transfer to up-regulate expression of 5a-reductase and 3aHSD in the NTS also normalises HPA axis responses in female PNS rats (158) . Notably, peripheral allopregnanolone treatment is ineffective in the prenatally stressed male siblings that also display hyperactive HPA axis responses to acute stress (Fig. 3B ). However, short-term treatment with 3b-diol, a metabolite of testosterone, does reverse the enhanced HPA axis responses to stress in PNS males, measured as significant reductions in ACTH ( Fig. 3C ) and corticosterone secretion, as well as CRH mRNA expression in the PVN (158) , and reduces anxiety-like behaviour on the elevated plus maze (M. V. Donadio, J. A. Russell and P. J. Brunton, unpubl. data). Testosterone replacement also normalises behaviour in the open field and prepulse inhibition responses (the deficits of which are seen in some neurodevelopmental disorders such as schizophrenia and attention deficit disorder) in adult prenatally stressed guinea pigs, as well as having a tendency for reversing elevated ACTH secretion under basal conditions (173) . Whether this is the result of a direct action of testosterone or an indirect action via one of its metabolites (e.g. DHT, 3a-diol or 3b-diol) is not known.
The mechanisms by which neuroactive steroids normalise neuroendocrine responses to stress in animals exposed to early-life stress remain to be elucidated. As described above, the potent action of allopregnanolone on GABA A receptors in supressing HPA axis activity (44) , indicates that GABA A receptors are a likely target. By contrast to allopregnanolone, 3b-diol evidently exerts its effect on the HPA axis via ERb (114) . ERb is expressed in the PVN (including in CRH neurones) and NTS (174, 175) , indicating that there is the potential for either direct or indirect modulation of HPA axis activity by 3b-diol. Indeed, agonists selective for ERb have anxiolytic and antidepressive actions and attenuate swim stress-induced corticosterone secretion in rats (176) . reduces cell death and cognitive impairments that result from brain injury or cerebral ischaemia (177, 178) and reverse cognitive deficits in a mouse model of Alzheimer's disease (152) . Whether neuroactive steroid treatment also reverses cognitive impairments associated with early-life stress, as has been shown for HPA axis dysfunction and anxiety behaviour (158, 172) , remains to be determined.
Cognitive deficits

Summary and outlook
Animal studies clearly demonstrate that exposure to stress during early-life programmes the brain and subsequent behaviour. HPA axis dysregulation is a common feature of the 'programmed' phenotype and may contribute to heightened anxiety behaviour and cognitive deficits. Similarly, stress exposure during development in humans apparently increases the propensity for psychiatric disorders and cognitive impairments. Neuroactive steroids play a critical role in brain development and can modulate HPA axis activity and influence anxiety behaviour and cognitive performance. There is growing evidence that exposure to stress in early life reduces the capacity of the brain for neurosteroidogenesis and may also alter the ability of neuroactive steroids to exert their actions (Fig. 4) . Whether altered neuroactive steroid sensitivity results from variations in the number (47) , the subunit composition (179) or the phosphorylation status of the GABA A receptors (180) remains to be elucidated. Moreover, the mechanisms underlying the reduction in the brains ability to generate neurosteroids (e.g. by down-regulation of 5a-reductase gene expression) also requires further study; whether this involves epigenetic mechanisms or results from increased exposure to androgens during critical periods of brain development is not yet known. Nonetheless, neuroactive steroids can counteract some of the adverse effects of earlylife stress exposure, such as HPA axis dysregulation and heightened anxiety behaviour (Figs 3 and 4) ; however, there are sex differences in the underlying central mechanisms.
The possibility that the adverse effects of early-life stress may be reversed by manipulating neuroactive steroids is a promising proposition that warrants further research and may have important implications for the development of new treatments for human stress-related conditions, which could be tailored according to sex. Fig. 4 . Early-life stress and neuroactive steroids. Stress in early life results in a persistent reduction in 5a-reductase (5aR) activity in the brain and liver, leading to a reduction in central neuroactive steroid levels (e.g. allopregnanolone, AP; dihydroprogesterone, DHP; dihydrotestosterone, DHT; 3a-androstandiol, 3a-diol; 3b-androstandiol, 3b-diol). This is associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, heightened anxiety-like behaviour and impaired cognitive ability. Some of these adverse phenotypes can be reversed with neuroactive steroid treatment/replacement. There is also evidence that early-life stress leads to a reduction in the central expression of the targets for neuroactive steroid action e.g. GABA A receptor (GABA A -R) and oestrogen receptor-b (ERb) and that AP is less effective in suppressing corticotrophin-releasing hormone (CRH) neuronal activity. ↑, increased; ↓, decreased.
